Tavros Therapeutics

Tavros Therapeutics is developing first-class targeted cancer therapies. Tavros Therapeutics is a science-first company that believes the future of cancer treatment lies in determining how to optimally position drugs clinically through an in-depth understanding of drug biology. We utilize cutting-edge functional genomics technologies to uncover unique vulnerabilities within tumors, discovering context-specific cancer drugs, targets, and approaches. We are committed to improving outcomes for cancer patients by developing next-generation targeted cancer therapies.